DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Hilton Cairo Heliopolis

2026年12月01日 (火) 午後 5:30 - 2026年12月03日 (木) 午後 5:00

El-Orouba, Sheraton Al Matar, El Nozha, 11361 Cairo Governorate, Egypt

Africa Access Summit 2026

Global Expertise | Regional Priorities | Shared Commitment. Working Together to Strengthen Healthcare Delivery and Improve Patient Access.

CONTACT US
Send Email

Session 3B: Advancing Africa’s Clinical Trial Ecosystem: From Readiness to Global Competitiveness

Session Chair(s)

Elizabeth C. Smith

Elizabeth C. Smith

Deputy Director, Regulatory Affairs, Gates Foundation, United States

Christopher  Obwanga

Christopher Obwanga

Sr. Director, Clinical Operations, Africa, IQVIA, Kenya

Africa presents the opportunity to move from being an underrepresented (<4% of Global trials) trial location to becoming a globally competitive clinical research partner. To increase Africa’s participation, a coordinated and integrated approach across regulatory and ethics review, research infrastructure, investigator and workforce development, earl-phase clinical trial capability, community engagement genomic representation, digital systems and sustainable investment is required. The session will bring together diverse stakeholders across the clinical trial value chain to identify practical actions that can increase access and impact of clinical trials conducted across Africa.

Speaker(s)

Ola  Abd Elghany

Speaker

Ola Abd Elghany

Manager of protocol and studies follow up administration , Egyptian Drug Authority, Egypt

Wilfred  Gurupira

Speaker

Wilfred Gurupira

Global Health & Clinical Research Executive, Africa Clinical Research Network (ACRN), Zimbabwe

Kwasi   Nyarko, MD

Speaker

Kwasi Nyarko, MD

Technical Officer, Implementation Research Portfolio Coordinator,AVAREF Secret, WHO-AFRO, Congo, Democratic Republic of the

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。